After the FDA posted a recall notice yesterday related to Abbott’s implantable pulse generator that’s used with the company’s Proclaim and Infinity systems, a company spokesman issued the following additional background in a statement issued to The Fly: “Abbott has received reports indicating the loss of Bluetooth connectivity between Abbott’s implantable Proclaim and Infinity systems and its paired patient controller after a patient has undergone an MRI. Based on these occurrences, Abbott previously updated the patient controller Instructions for Use – IFU – and patient controller application MRI-mode screen on smartphones reminding the patient to not delete the paired Bluetooth connection between their Implantable Pulse Generator – IPG – and the patient controller. Abbott has distributed a physician communication to reinforce the importance of following the steps regarding MRI scans outlined in the IFU. The company has communicated this action to physicians and regulatory bodies. No products need to be returned to the company or replaced. Importantly, physicians can continue to use the Proclaim and Infinity systems.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ABT:
- FDA identifies Abbott Proclaim recall as Class I
- Abbott to Acquire Bigfoot Biomedical, Furthering Efforts to Develop Personalized, Connected Solutions for People with Diabetes
- Abbott to acquire Bigfoot for undisclosed amount
- Jefferies healthcare analyst holds an analyst/industry conference call
- FDA clears Abbott’s Alinity h-series hematology system